Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 2 September 2024

September 2, 2024
Language flag

Phase Holographic Imaging PHI AB (publ) (“PHI” or the “Company”) held an extraordinary general meeting on 2 September 2024. The following resolutions were passed at the meeting.

For the period until the next annual general meeting, the extraordinary general meeting resolved to elect John Moore as new ordinary board member.

John Moore is an active investor and entrepreneur in the life science and energy industries. He currently serves as Chairman of two public life science companies Nyrada (NYR-ASX) and Scientific Industries (SCND-OTCQB) and two private companies Trialogics, a clinical trial software business and Cormetech, a leading carbon capture business.

Subscribe to PHI news on cision.com

Additional reading

Interview-John-More-website

Interview with John Moore

Meet John Moore, the proposed new board member for PHI. John’s extensive experience and visionary mindset make him an invaluable addition to our team. Let’s dive into his journey and what made him interested in PHI.

Latest News

Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB 2 December 2024

Phase Holographic Imaging PHI AB (publ), 556542-7811 (the “Company”) will hold an Extraordinary General Meeting on 2 December 2024 at 15.00 CET at the Company’s premises, Skiffervägen 48 in Lund.

PHI resolves on a fully secured rights issue of shares of approximately SEK 64.3 million

The Board of Directors of Phase Holographic Imaging PHI AB has today resolved on a rights issue of shares, with preferential rights for the Company’s existing shareholders, of approximately SEK 64.3 million before deduction of issue related costs, subject to approval by the extraordinary general meeting to be held on 2 December 2024. The purpose of the Rights Issue is to fund a strategic development plan and to strengthen the Company’s capital structure by repayment/off-setting of outstanding loans.

Adopting the final Annual Report

PHI intends to convene a general meeting to adopt the annual report for the fiscal year 2023/2024 and to amend resolutions regarding election of board members and the number of board members.
See All News